CAD 0.03
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -7.66 Million USD | -117.93% |
2022 | -3.51 Million USD | -699.24% |
2021 | 587.32 Thousand USD | 113.72% |
2020 | -4.28 Million USD | -111.0% |
2019 | -2.02 Million USD | -3.04% |
2018 | -1.96 Million USD | -459.02% |
2017 | -352.28 Thousand USD | -172.43% |
2016 | -129.31 Thousand USD | 16.18% |
2015 | -154.26 Thousand USD | 50.8% |
2014 | -313.55 Thousand USD | 12.8% |
2013 | -359.56 Thousand USD | 62.53% |
2012 | -959.49 Thousand USD | -103.3% |
2011 | -471.94 Thousand USD | -188.27% |
2010 | -163.71 Thousand USD | -56.17% |
2009 | -104.83 Thousand USD | -5723.94% |
2008 | -1800.00 USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -844.07 Thousand USD | 27.43% |
2024 Q3 | -1.33 Million USD | -58.64% |
2024 Q1 | -1.16 Million USD | 49.46% |
2023 Q3 | -1.62 Million USD | 7.64% |
2023 FY | -7.66 Million USD | -117.93% |
2023 Q4 | -2.3 Million USD | -41.36% |
2023 Q1 | -1.97 Million USD | -7.52% |
2023 Q2 | -1.76 Million USD | 10.89% |
2022 Q2 | -1.12 Million USD | -545.17% |
2022 FY | -3.51 Million USD | -699.24% |
2022 Q4 | -1.83 Million USD | -41.23% |
2022 Q3 | -1.3 Million USD | -16.19% |
2022 Q1 | 251.84 Thousand USD | -34.09% |
2021 Q3 | 707.95 Thousand USD | 267.67% |
2021 Q4 | 382.12 Thousand USD | -46.02% |
2021 FY | 587.32 Thousand USD | 113.72% |
2021 Q1 | -695.3 Thousand USD | 43.32% |
2021 Q2 | 192.55 Thousand USD | 127.69% |
2020 Q1 | -1.32 Million USD | 1.59% |
2020 FY | -4.28 Million USD | -111.0% |
2020 Q4 | -1.22 Million USD | 28.42% |
2020 Q3 | -1.71 Million USD | -38.57% |
2020 Q2 | -1.23 Million USD | 6.49% |
2019 Q3 | -75.67 Thousand USD | 94.65% |
2019 Q4 | -1.34 Million USD | -1675.97% |
2019 FY | -2.02 Million USD | -3.04% |
2019 Q1 | -9113.00 USD | 98.09% |
2019 Q2 | -1.41 Million USD | -15415.07% |
2018 FY | -1.96 Million USD | -459.02% |
2018 Q4 | -477.54 Thousand USD | -235.78% |
2018 Q3 | -142.21 Thousand USD | 85.38% |
2018 Q2 | -972.86 Thousand USD | -158.25% |
2018 Q1 | -376.71 Thousand USD | -69.71% |
2017 Q2 | -36.14 Thousand USD | -248.45% |
2017 Q1 | -10.37 Thousand USD | 66.44% |
2017 Q4 | -221.98 Thousand USD | -164.93% |
2017 FY | -352.28 Thousand USD | -172.43% |
2017 Q3 | -83.78 Thousand USD | -131.84% |
2016 Q4 | -30.9 Thousand USD | 15.5% |
2016 FY | -129.31 Thousand USD | 16.18% |
2016 Q2 | -31.8 Thousand USD | -5.96% |
2016 Q3 | -36.57 Thousand USD | -14.99% |
2016 Q1 | -30.02 Thousand USD | -2.25% |
2015 Q2 | -43.76 Thousand USD | 0.65% |
2015 Q4 | -29.35 Thousand USD | 20.85% |
2015 FY | -154.26 Thousand USD | 50.8% |
2015 Q1 | -44.05 Thousand USD | -12.24% |
2015 Q3 | -37.09 Thousand USD | 15.25% |
2014 Q3 | -40.96 Thousand USD | 74.86% |
2014 FY | -313.55 Thousand USD | 12.8% |
2014 Q1 | -68.94 Thousand USD | -21.91% |
2014 Q2 | -162.98 Thousand USD | -136.41% |
2014 Q4 | -39.24 Thousand USD | 4.2% |
2013 Q1 | -116.44 Thousand USD | 71.79% |
2013 FY | -359.56 Thousand USD | 62.53% |
2013 Q4 | -56.55 Thousand USD | 40.09% |
2013 Q3 | -94.39 Thousand USD | -2.4% |
2013 Q2 | -92.17 Thousand USD | 20.84% |
2012 FY | -959.49 Thousand USD | -103.3% |
2012 Q3 | -175.04 Thousand USD | 0.28% |
2012 Q2 | -175.53 Thousand USD | 10.48% |
2012 Q1 | -196.07 Thousand USD | 31.95% |
2012 Q4 | -412.83 Thousand USD | -135.85% |
2011 Q1 | -22.2 Thousand USD | 54.28% |
2011 FY | -471.94 Thousand USD | -188.27% |
2011 Q3 | -101.01 Thousand USD | -66.67% |
2011 Q2 | -60.6 Thousand USD | -172.92% |
2011 Q4 | -288.12 Thousand USD | -185.23% |
2010 Q4 | -48.56 Thousand USD | 15.27% |
2010 Q3 | -57.32 Thousand USD | -99.51% |
2010 FY | -163.71 Thousand USD | -56.17% |
2010 Q1 | -29.09 Thousand USD | 17.44% |
2010 Q2 | -28.73 Thousand USD | 1.26% |
2009 Q1 | -34.59 Thousand USD | 0.0% |
2009 Q4 | -35.24 Thousand USD | -24.28% |
2009 Q2 | -26.38 Thousand USD | 23.72% |
2009 Q3 | -28.36 Thousand USD | -7.47% |
2009 FY | -104.83 Thousand USD | -5723.94% |
2008 FY | -1800.00 USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | -544.019% |
Ayurcann Holdings Corp. | -3.25 Million CAD | -135.934% |
Blueberries Medical Corp. | -1.22 Million CAD | -525.316% |
The BC Bud Corporation | -1.22 Million CAD | -526.896% |
BioNxt Solutions Inc. | -6.36 Million CAD | -20.458% |
CordovaCann Corp. | -2.51 Million CAD | -205.264% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -771.042% |
Captor Capital Corp. | 655.2 Thousand CAD | 1270.61% |
City View Green Holdings Inc. | -996.45 Thousand CAD | -669.726% |
1CM Inc. | 300.79 Thousand CAD | 2649.923% |
Global Hemp Group Inc. | -551.7 Thousand CAD | -1290.217% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | -97.725% |
IM Cannabis Corp. | -12.17 Million CAD | 37.003% |
Lobe Sciences Ltd. | -3.35 Million CAD | -128.314% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -1855.54% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | -140.739% |
Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 1514.413% |
Ovation Science Inc. | -764 Thousand CAD | -903.908% |
Pharmadrug Inc. | -1.33 Million CAD | -474.522% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | -571.638% |
RAMM Pharma Corp. | -7.08 Million CAD | -8.239% |
RIV Capital Inc. | 1.78 Million CAD | 530.838% |
Revive Therapeutics Ltd. | -3.28 Million CAD | -133.41% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | 12.534% |
SLANG Worldwide Inc. | -5.98 Million CAD | -28.123% |
1933 Industries Inc. | -9.34 Million CAD | 17.963% |
Red Light Holland Corp. | -6.44 Million CAD | -18.98% |
Top Strike Resources Corp. | -784.8 Thousand CAD | -877.309% |
Xebra Brands Ltd. | -1.55 Million CAD | -393.39% |
Adastra Holdings Ltd. | -1.79 Million CAD | -327.59% |